Format

Send to

Choose Destination
See comment in PubMed Commons below
Surg Today. 2013 Nov;43(11):1232-9. doi: 10.1007/s00595-012-0458-4. Epub 2013 Feb 23.

Mixed corticomedullary adrenal carcinoma.

Author information

1
3rd Department of Surgery, Aristotle University of Thessaloniki, AHEPA University Hospital, 85 Karakasi Str, 54453, Thessaloniki, Greece, nickos.michalopoulos@gmail.com.

Abstract

Truly mixed corticomedullary tumors (MCMTs) are extremely rare and present as a single tumor mass composed of an intimately admixed population of both adrenal cortical cells and pheochromocytes. The current study describes the first case of a mixed corticomedullary adrenal carcinoma. In addition, we also review the published data on MCMTs to determine their clinical features, biochemical characteristics, pathological findings, and management. In order to compose this review, a search of the international literature for MCMTs was conducted. Fifteen related articles were found. The clinical and pathological information was obtained for all reported cases. MCMTs were found almost exclusively in females. In the vast majority of patients, the symptoms were related to the tumor's hormone hypersecretion. Hypertension and diabetes were present in 80 and 40 % of cases, respectively. Cushing's syndrome was reported in eight cases (53.33 %). A final diagnosis was made in all cases after surgery based on the pathological results. As of the writing of this article, all published cases of MCMTs had benign clinical behavior, with no instances of metastasis or death due to the tumor. MCMTs are currently considered to be benign tumors. Ours is the first case of malignant MCMT reported in the literature. The potential for malignancy should therefore be considered for these tumors.

PMID:
23435808
DOI:
10.1007/s00595-012-0458-4
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center